Literature DB >> 31436472

MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.

Xiaofei Xu1, Xiaofei Jiang2, Liping Chen3, Yu Zhao4, Zhihua Huang5, Huifang Zhou6, Mingqing Shi1.   

Abstract

Objective: In this study, the authors established a cervical cancer cisplatin (DDP) drug-resistant cell line to explore the role of miR-181a in the regulation of osteopontin (OPN) expression and the proliferation, apoptosis, as well as DDP resistance of cervical cancer cells. Materials and
Methods: Dual luciferase reporter gene assay was performed to validate the targeted relationship between miR-181a and OPN. The DDP-resistant cell line CaSki/DDP was established to compare the expressions of miR-181a and OPN. The cell proliferation activity was detected by CCK-8 assay. CaSki/DDP cells were divided into miR-NC group and miR-181a mimic group followed by analysis of cell apoptosis by flow cytometry, and the cell proliferation by EdU staining.
Results: There was a targeted relationship between miR-181a and OPN mRNA. MiR-181a expression was significantly lower, while OPN mRNA and protein levels were significantly higher in CaSki/DDP cells than that in CaSki cells. Compared with the miR-NC group, OPN mRNA and protein were significantly decreased, cell apoptosis was significantly increased, and cell proliferation ability was significantly attenuated in miR-181a mimic transfection group. Conclusions: The decrease of miR-181a expression and the upregulation of OPN expression are related to the DDP resistance of cervical cancer cells. Overexpression of miR-181a can inhibit the expression of OPN, induce cell apoptosis cells, restrain cell proliferation, and reduce DDP resistance in cervical cancer cells.

Entities:  

Keywords:  DDP; OPN; cervical cancer; drug resistance; miR-181a

Mesh:

Substances:

Year:  2019        PMID: 31436472     DOI: 10.1089/cbr.2019.2858

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  8 in total

1.  Biological and Clinicopathological Characteristics of OPN in Cervical Cancers.

Authors:  Shuhang Qin; Li Yi; Yanchun Liang; Yili Chen; Wei Wang; Yuandong Liao; Chunyu Zhang; Hua Huang; Jiaming Huang; Shuzhong Yao
Journal:  Front Genet       Date:  2022-05-20       Impact factor: 4.772

2.  [Effect of small interfering RNA-mediated BIRC6 silencing on apoptosis and autophagy of renal cancer 786-O cells].

Authors:  Kaihua Zhong; Dong Chen; Zhiming Wu; Xiaohong Wang; Bin Pan; Nanhui Chen; Weifeng Zhong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

Review 3.  Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.

Authors:  Asal Jalal Abadi; Ali Zarrabi; Mohammad Hossein Gholami; Sepideh Mirzaei; Farid Hashemi; Amirhossein Zabolian; Maliheh Entezari; Kiavash Hushmandi; Milad Ashrafizadeh; Haroon Khan; Alan Prem Kumar
Journal:  Biomolecules       Date:  2021-02-18

4.  MicroRNA-92a-3p Enhances Cisplatin Resistance by Regulating Krüppel-Like Factor 4-Mediated Cell Apoptosis and Epithelial-to-Mesenchymal Transition in Cervical Cancer.

Authors:  Jing Yang; Jing Hai; Xuecai Dong; Mengjie Zhang; Shufeng Duan
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

5.  Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.

Authors:  Xili Jiang; Wei Zhang; Lifeng Li; Shucai Xie
Journal:  Pathol Oncol Res       Date:  2021-10-19       Impact factor: 3.201

6.  The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines.

Authors:  Dominika Kazmierczak; Karol Jopek; Karolina Sterzynska; Barbara Ginter-Matuszewska; Michal Nowicki; Marcin Rucinski; Radoslaw Januchowski
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

Review 7.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27

Review 8.  The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.

Authors:  Rina Masadah; Syahrul Rauf; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.